Quantification of beta-defensin copy number variable genes in relation to inflammation in diabetic patients

Beta-defensins is one of the predominant antimicrobial peptide which serves as the first line defence against broad spectrum of microbes, including fungi and some viruses. These peptides are encoded by beta-defensins gene; which is variable in copy number. Copy number variations (CNVs) of beta-defen...

Full description

Bibliographic Details
Main Author: Yusoff, Maryam Jamielah
Format: Thesis
Language:English
Published: 2015
Subjects:
Online Access:http://psasir.upm.edu.my/id/eprint/103829/
http://psasir.upm.edu.my/id/eprint/103829/1/MARYAM%20JAMIELAH%20BINTI%20YUSOFF%20-%20IR.pdf
_version_ 1848864118775218176
author Yusoff, Maryam Jamielah
author_facet Yusoff, Maryam Jamielah
author_sort Yusoff, Maryam Jamielah
building UPM Institutional Repository
collection Online Access
description Beta-defensins is one of the predominant antimicrobial peptide which serves as the first line defence against broad spectrum of microbes, including fungi and some viruses. These peptides are encoded by beta-defensins gene; which is variable in copy number. Copy number variations (CNVs) of beta-defensins is present in healthy population. Nevertheless, studies from the past decades have found that beta-defensins gene CNVs also contributed to several inflammatory diseases. Therefore, the objective of this study is to investigate the relationship between copy number variation of beta-defensins with inflammatory condition in type 2 diabetes (T2D). It is hypothesised that copy number variation of beta-defensins contributes to development of T2D through modification of immune response products dosage that exert attacks on host cell that contributed to inflammatory condition in T2D patients. DNA samples from 146 control and 392 T2D individuals were extracted for this study. Beta-defensins copy number quantification was carried out by using paralogue ratio test (PRT107A and HSPD21 primers) and validated by indel polymorphism measurement (5DEL primer) and two microsatellite analysis (EPEV-1 and EPEV-3 primers). Based on the analysis, the copy number variation is more extensive in T2D population ranging between 1 and 12 copies; with copy number 1, 10 and 12 detected in nephropathy group, while in control population the copy number varies between 2 and 8 copies. However, the distribution of copy number are not statistically significant between T2D and control (p=0.209) and between those with and without nephropathy among T2D population (p=0.522). Despite the result, the white blood cell count between individuals with and without nephropathy from T2D population is significantly different (p=0.000). In conclusion, future studies are needed to further explore the true potential of copy number variation of beta-defensins gene towards development of nephropathy in T2D patients.
first_indexed 2025-11-15T13:43:44Z
format Thesis
id upm-103829
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T13:43:44Z
publishDate 2015
recordtype eprints
repository_type Digital Repository
spelling upm-1038292023-05-09T07:51:30Z http://psasir.upm.edu.my/id/eprint/103829/ Quantification of beta-defensin copy number variable genes in relation to inflammation in diabetic patients Yusoff, Maryam Jamielah Beta-defensins is one of the predominant antimicrobial peptide which serves as the first line defence against broad spectrum of microbes, including fungi and some viruses. These peptides are encoded by beta-defensins gene; which is variable in copy number. Copy number variations (CNVs) of beta-defensins is present in healthy population. Nevertheless, studies from the past decades have found that beta-defensins gene CNVs also contributed to several inflammatory diseases. Therefore, the objective of this study is to investigate the relationship between copy number variation of beta-defensins with inflammatory condition in type 2 diabetes (T2D). It is hypothesised that copy number variation of beta-defensins contributes to development of T2D through modification of immune response products dosage that exert attacks on host cell that contributed to inflammatory condition in T2D patients. DNA samples from 146 control and 392 T2D individuals were extracted for this study. Beta-defensins copy number quantification was carried out by using paralogue ratio test (PRT107A and HSPD21 primers) and validated by indel polymorphism measurement (5DEL primer) and two microsatellite analysis (EPEV-1 and EPEV-3 primers). Based on the analysis, the copy number variation is more extensive in T2D population ranging between 1 and 12 copies; with copy number 1, 10 and 12 detected in nephropathy group, while in control population the copy number varies between 2 and 8 copies. However, the distribution of copy number are not statistically significant between T2D and control (p=0.209) and between those with and without nephropathy among T2D population (p=0.522). Despite the result, the white blood cell count between individuals with and without nephropathy from T2D population is significantly different (p=0.000). In conclusion, future studies are needed to further explore the true potential of copy number variation of beta-defensins gene towards development of nephropathy in T2D patients. 2015-06 Thesis NonPeerReviewed text en http://psasir.upm.edu.my/id/eprint/103829/1/MARYAM%20JAMIELAH%20BINTI%20YUSOFF%20-%20IR.pdf Yusoff, Maryam Jamielah (2015) Quantification of beta-defensin copy number variable genes in relation to inflammation in diabetic patients. Masters thesis, Universiti Putra Malaysia. Beta - Defensins Genes - Drug effects Diabetes Mellitus - Genetics
spellingShingle Beta - Defensins
Genes - Drug effects
Diabetes Mellitus - Genetics
Yusoff, Maryam Jamielah
Quantification of beta-defensin copy number variable genes in relation to inflammation in diabetic patients
title Quantification of beta-defensin copy number variable genes in relation to inflammation in diabetic patients
title_full Quantification of beta-defensin copy number variable genes in relation to inflammation in diabetic patients
title_fullStr Quantification of beta-defensin copy number variable genes in relation to inflammation in diabetic patients
title_full_unstemmed Quantification of beta-defensin copy number variable genes in relation to inflammation in diabetic patients
title_short Quantification of beta-defensin copy number variable genes in relation to inflammation in diabetic patients
title_sort quantification of beta-defensin copy number variable genes in relation to inflammation in diabetic patients
topic Beta - Defensins
Genes - Drug effects
Diabetes Mellitus - Genetics
url http://psasir.upm.edu.my/id/eprint/103829/
http://psasir.upm.edu.my/id/eprint/103829/1/MARYAM%20JAMIELAH%20BINTI%20YUSOFF%20-%20IR.pdf